Jaffetilchin Investment Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $409K | Buy |
+5,924
| New | +$409K | 0.03% | 284 |
|
|
2024
Q4 | – | Sell |
-594
| Closed | -$70.7K | – | 968 |
|
|
2024
Q3 | $70.7K | Buy |
+594
| New | +$70.7K | 0.01% | 508 |
|
|
2016
Q1 | – | Sell |
-12,798
| Closed | -$372K | – | 228 |
|
|
2015
Q4 | $372K | Buy |
12,798
+788
| +7% | +$22.9K | 0.12% | 116 |
|
|
2015
Q3 | $326K | Sell |
12,010
-4,978
| -29% | -$135K | 0.12% | 130 |
|
|
2015
Q2 | $465K | Buy |
+16,988
| New | +$465K | 0.14% | 127 |
|
|
2014
Q3 | – | Sell |
-17,010
| Closed | -$393K | – | 232 |
|
|
2014
Q2 | $393K | Buy |
+17,010
| New | +$393K | 0.14% | 111 |
|
|
2014
Q1 | – | Sell |
-17,400
| Closed | -$321K | – | 213 |
|
|
2013
Q4 | $321K | Buy |
17,400
+1,480
| +9% | +$27.3K | 0.16% | 130 |
|
|
2013
Q3 | $269K | Sell |
15,920
-22,100
| -58% | -$373K | 0.16% | 145 |
|
|
2013
Q2 | $589K | Buy |
+38,020
| New | +$589K | 0.41% | 65 |
|